February 9, 2025 - 00:26

In a heartfelt conversation at the 32nd Annual Movieguide Awards, Candace Cameron Bure shared insights about her longtime friend and 'Full House' co-star, Dave Coulier. She revealed that she frequently reaches out to Coulier, who is currently undergoing treatment for stage 3 non-Hodgkin lymphoma, a diagnosis he received in October 2024.
Bure expressed her admiration for Coulier's resilience during this challenging time, emphasizing that he remains optimistic and strong as he navigates his recovery journey. The support from friends and family has been crucial for Coulier, and Bure's regular check-ins serve as a reminder of their enduring bond.
As fans continue to rally behind him, Bure's updates bring a sense of hope and solidarity. The entertainment community stands united in sending positive thoughts and prayers for Coulier's health and well-being as he fights this battle with courage and determination.
October 16, 2026 - 02:28
Bipartisan Push Gains Ground on Youth Mental HealthThe mental health crisis affecting young Americans did not start with the COVID-19 pandemic, but the events of the past few years made it far worse. More than 40 percent of teenagers have reported...
October 15, 2026 - 11:16
Duke Health and CaroMont Health Pursue Two New Hospitals in Mecklenburg CountyDuke Health and CaroMont Health have announced a partnership aimed at building two new hospitals in Mecklenburg County. The move marks the latest development in a growing wave of hospital expansion...
October 14, 2026 - 22:23
Zocdoc Buys Sohar Health to Expand Insurance Verification ToolsZocdoc acquired insurance technology company Sohar Health as it pushes to evolve beyond an appointment-booking marketplace into broader healthcare access infrastructure. The deal adds automated...
October 14, 2026 - 08:31
Understanding Childhood Vaccines: A Pediatrician Answers Common QuestionsParents often have questions about the vaccines their children receive. To help address these concerns, a trusted pediatrician offers clear answers on the topic. One common question is whether the...